NASDAQ
Bioxytran, Inc. (BIXT) has a free cash flow growth of 5.36% as of Friday, May 29, 2026. This represents a 101.57% increase compared to its 12-month average of -341.51%. Free cash flow growth tracks the year-over-year percentage change in cash generated after capital expenditures.
No price data available for this timeframe.